Xiao Wang

Discovery of <b>BWA-522</b>, a First-in-Class and Orally Bioavailable PROTAC Degrader of the Androgen Receptor Targeting N-Terminal Domain for the Treatment of Prostate Cancer

Bowen Zhang, Chang Liu, Zhenqian Yang et al. · Journal of Medicinal Chemistry · 2023 · 36 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Diastereoselective Synthesis of Cyclopentanoids: Applications to the Construction of the ABCD Tetracyclic Core of Retigeranic Acid A

Jun-Lin Zhang, Xiao Wang, Shuang Li et al. · Chemistry - A European Journal · 2015 · 27 citations

Natural Sciences, Chemistry, Medicinal Chemistry +10

Pilot Study of Nectin-4–Targeted PET Imaging Agent⁶⁸Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human

Li Sun, Yuyun Sun, Ke Zuo et al. · Journal of Nuclear Medicine · 2025 · 24 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Design, Synthesis, and Biological Evaluation of Androgen Receptor (AR) Antagonist-Heat Shock Protein 90 (Hsp90) Inhibitor Conjugates for Targeted Therapy of Castration-Resistant Prostate Cancer

Siqi Zhang, Xiao-Lei Meng, Sai Zhang et al. · Journal of Medicinal Chemistry · 2023 · 15 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

A Potent SOS1 PROTAC Degrader with Synergistic Efficacy in Combination with KRAS^G12C Inhibitor

Yan Lv, Zixuan Yang, Yiming Chen et al. · Journal of Medicinal Chemistry · 2024 · 15 citations · Full text

Medicine, Oncology, Pharmacology +16